Managers / Q2 2021 · view latest →
Rovida Advisors Inc.
CIK 0001653857 · C/O SMAART COMPANY, 2319 N. ANDREWS AVENUE, FORT LAUDERDALE, FL, 33311 · 345-949-4700
Summary
Rovida Advisors Inc. reported $2.3B in U.S.-listed holdings across 47 positions for Q2 2021.
Its largest position, Dada Nexus, represents 9.3% of the portfolio.
Compared with Q1 2021, the fund opened 7 new positions and exited 9.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 73.0% · $1.7B
- ADR · 25.9% · $598M
- Other · 1.1% · $24M
Quarter-over-Quarter Changes full breakdown →
vs Q1 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| COINCOINBASE GLOBAL INC | NEW | +235.6K | 235.6K | +$60M | $60M |
| BIDUBAIDU INC | NEW | +75.0K | 75.0K | +$15M | $15M |
| XMTRXOMETRY INC | NEW | +60.0K | 60.0K | +$5M | $5M |
| CREDIT SUISSE GROUP | NEW | +481.5K | 481.5K | +$5M | $5M |
| OGNORGANON & CO | NEW | +45.1K | 45.1K | +$1M | $1M |
| OSMOTICA PHARMACEUTICALS PLC | NEW | +300.3K | 300.3K | +$901,000 | $901,000 |
| EMGAEMAGIN CORP | NEW | +66.7K | 66.7K | +$231,000 | $231,000 |
| METAFACEBOOK INC | ADDED | +238.9K | 320.0K | +$87M | $111M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2021
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q4 2025 | $0 | 1 | Feb 10, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $116M | 12 | Nov 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $112M | 12 | Aug 12, 2025 | RESTATEMENT | changes · EDGAR ↗ |
| Q1 2025 | $134M | 12 | May 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $129M | 12 | Feb 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $318M | 23 | Nov 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $280M | 23 | Aug 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $288M | 26 | May 10, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $245M | 17 | Feb 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $263M | 19 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $229M | 18 | Aug 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $256M | 22 | May 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $272M | 25 | Feb 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $215M | 20 | Nov 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $389M | 25 | Aug 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $466M | 28 | May 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $2.2B | 48 | Feb 14, 2022 | RESTATEMENT | changes · EDGAR ↗ |
| Q3 2021 | $2.4B | 52 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $2.3B | 47 | Aug 10, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $2.1B | 49 | May 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $1.7B | 42 | Feb 9, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $1.4B | 49 | Nov 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $1.0B | 47 | Aug 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $213M | 26 | May 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $1.9B | 58 | Feb 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $1.7B | 39 | Nov 8, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $1.7B | 41 | Aug 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $1.5B | 40 | May 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $1.2B | 35 | Feb 11, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 1 additional manager.
- OMIT28-17040
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.